<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10358154" created="26/06/06" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10358154</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">New <term id="T1" lex="immunosuppressive_drug" sem="Organic_compound_other">immunosuppressive drug</term> <term id="T2" lex="PNU156804" sem="Organic_compound_other">PNU156804</term> blocks <term id="T3" lex="IL-2-dependent_proliferation"><term id="T4" lex="IL-2" sem="Protein_molecule">IL-2</term>-dependent <term id="A1" sem="Other">proliferation</term></term> and <cons id="T5" lex="(AND NF-kappa_B_activation AP-1_activation)" sem="(AND Other Other)"><frag id="F1"><term id="A2" sem="Protein_complex">NF-kappa B</term></frag> and <frag id="F2"><term id="A3" sem="Protein_molecule">AP-1</term></frag> <frag id="F3">activation</frag></cons>.</sentence>
<event id="E1">
<type class="Negative_regulation"/>
<theme idref="E4"/>
<cause idref="T2"/>
<clue>New immunosuppressive drug PNU156804 <clueType>blocks</clueType> IL-2-dependent proliferation and NF-kappa B and AP-1 activation.</clue>
</event>
<event id="E2">
<type class="Negative_regulation"/>
<theme idref="E5"/>
<cause idref="T2"/>
<clue>New immunosuppressive drug PNU156804 <clueType>blocks</clueType> IL-2-dependent proliferation and NF-kappa B and AP-1 activation.</clue>
</event>
<event id="E3">
<type class="Negative_regulation"/>
<theme idref="E6"/>
<cause idref="T2"/>
<clue>New immunosuppressive drug PNU156804 <clueType>blocks</clueType> IL-2-dependent proliferation and NF-kappa B and AP-1 activation.</clue>
</event>
<event KT="Other" id="E4">
<type class="Regulation"/>
<theme idref="A1"/>
<clue>New immunosuppressive drug PNU156804 blocks IL-2-<clueType>dependent</clueType> proliferation and NF-kappa B and AP-1 activation.</clue>
<comment>NER: T3 del &quot;IL-2-dependent proliferation&quot;</comment></event>
<event KT="Other" id="E5">
<type class="Positive_regulation"/>
<theme idref="A2"/>
<clue>New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 <clueType>activation</clueType>.</clue>
</event>
<event KT="Other" id="E6">
<type class="Positive_regulation"/>
<theme idref="A3"/>
<clue>New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 <clueType>activation</clueType>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">We had previously shown that the drug <term id="T6" lex="undecylprodigiosin" sem="Organic_compound_other">undecylprodigiosin</term> (<term id="T7" lex="UP" sem="Organic_compound_other">UP</term>) blocks <term id="T8" lex="human_lymphocyte_proliferation" sem="Other"><term id="T9" lex="human_lymphocyte" sem="Cell_natural">human lymphocyte</term> proliferation</term> in vitro.</sentence>
<event KT="Analysis" Source="Other" id="E7">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="T7"/>
<clue>We had <clueSource>previously</clueSource> <clueKT>shown</clueKT> that the drug undecylprodigiosin (UP) <clueType>blocks</clueType> human lymphocyte proliferation in vitro.</clue>
</event>
<event KT="Other" id="E8">
<type class="Cellular_physiological_process"/>
<theme idref="T9"/>
<clue>We had previously shown that the drug undecylprodigiosin (UP) blocks human lymphocyte <clueType>proliferation</clueType> in vitro.</clue>
</event>
<sentence id="S3">We have now investigated the mechanism of action of a new analogue of <term id="T10" lex="UP" sem="Organic_compound_other">UP</term>, <term id="T11" lex="PNU156804" sem="Organic_compound_other">PNU156804</term>, which shows a more favorable <term id="T12" lex="activity_profile" sem="Other">activity profile</term> than <term id="T13" lex="UP" sem="Organic_compound_other">UP</term> in <term id="T14" lex="mouse" sem="Multicellular_organism_natural">mice</term>.</sentence>
<event id="E9">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="T11"/>
<clue>We have now investigated the mechanism of action of a new analogue of UP, PNU156804, which <clueType>shows</clueType> a more favorable <clueType>activity profile</clueType> than UP <clueLoc>in mice</clueLoc>.</clue>
<comment>CAUTION: Negative_regulation, from the context in S2</comment></event>
<event id="E48">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="T13"/>
<clue>We have now investigated the mechanism of action of a new analogue of UP, PNU156804, which <clueType>shows</clueType> a more favorable <clueType>activity profile</clueType> than UP <clueLoc>in mice</clueLoc>.</clue>
<comment>CAUTION: Negative_regulation, from the context in S2</comment></event>
<sentence id="S4">We demonstrate here that the biological effect of <term id="T15" lex="PNU156804" sem="Organic_compound_other">PNU156804</term> in vitro is indistinguishable from <term id="T16" lex="UP" sem="Organic_compound_other">UP</term>: <term id="T17" lex="PNU156804" sem="Organic_compound_other">PNU156804</term> blocks <term id="T18" lex="human_T_cell_proliferation" sem="Other"><term id="T19" lex="human_T_cell" sem="Cell_natural">human T cell</term> proliferation</term> in <term id="T20" lex="mid-late_G1" sem="Other">mid-late G1</term>, as determined by <term id="T21" lex="cell_cycle_analysis" sem="Other"><term id="T57" lex="cell_cycle" sem="Other">cell cycle</term> analysis</term>, expression of <term id="T22" lex="cyclin" sem="Protein_family_or_group">cyclins</term>, and <term id="T23" lex="cyclin-dependent_kinase" sem="Protein_family_or_group">cyclin-dependent kinases</term> and <term id="T24" lex="retinoblastoma_phosphorylation" sem="Other"><term id="A4" sem="Protein_family_or_group">retinoblastoma</term> phosphorylation</term>.</sentence>
<event KT="Analysis" id="E10">
<type class="Negative_regulation"/>
<theme idref="E11"/>
<cause idref="T17"/>
<clue>We demonstrate here that the biological effect of PNU156804 in vitro is indistinguishable from UP: PNU156804 <clueType>blocks</clueType> human T cell proliferation in mid-late G1, as <clueKT>determined</clueKT> by cell cycle analysis, expression of cyclins, and cyclin-dependent kinases and retinoblastoma phosphorylation.</clue>
</event>
<event KT="Other" id="E11">
<type class="Cellular_physiological_process"/>
<theme idref="T19"/>
<clue>We demonstrate here that the biological effect of PNU156804 in vitro is indistinguishable from UP: PNU156804 blocks human T cell <clueType>proliferation</clueType> in mid-late G1, as determined <clueExperiment>by cell cycle analysis, expression of cyclins, and cyclin-dependent kinases and retinoblastoma phosphorylation</clueExperiment>.</clue>
</event>
<event KT="Other" id="E49" uncertainty="doubtful">
<type class="Cellular_physiological_process"/>
<theme idref="T19"/>
<clue>We demonstrate here that the biological effect of PNU156804 in vitro is indistinguishable from UP: PNU156804 blocks human T cell proliferation in mid-late G1, as determined by <clueType>cell cycle</clueType> analysis, expression of cyclins, and cyclin-dependent kinases and retinoblastoma phosphorylation.</clue>
</event>
<event KT="Other" id="E12" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="T22"/>
<clue>We demonstrate here that the biological effect of PNU156804 in vitro is indistinguishable from UP: PNU156804 blocks human T cell proliferation in mid-late G1, as determined by cell cycle analysis, <clueType>expression</clueType> <linkTheme>of</linkTheme> cyclins, and cyclin-dependent kinases and retinoblastoma phosphorylation.</clue>
</event>
<event KT="Other" id="E13" uncertainty="doubtful">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T23"/>
<clue>We demonstrate here that the biological effect of PNU156804 in vitro is indistinguishable from UP: PNU156804 blocks human T cell proliferation in mid-late G1, as determined by cell cycle analysis, expression of cyclins, and cyclin-dependent kinases and retinoblastoma <clueType>phosphorylation</clueType>.</clue>
</event>
<event KT="Other" id="E14" uncertainty="doubtful">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="A4"/>
<clue>We demonstrate here that the biological effect of PNU156804 in vitro is indistinguishable from UP: PNU156804 blocks human T cell proliferation in mid-late G1, as determined by cell cycle analysis, expression of cyclins, and cyclin-dependent kinases and retinoblastoma <clueType>phosphorylation</clueType>.</clue>
</event>
<event KT="Analysis" id="E15">
<type class="Negative_regulation"/>
<theme idref="E11"/>
<cause idref="T16"/>
<clue>We <clueKT>demonstrate</clueKT> here that the biological effect of PNU156804 in vitro is indistinguishable from UP: PNU156804 <clueType>blocks</clueType> human T cell proliferation in mid-late G1, as determined by cell cycle analysis, expression of cyclins, and cyclin-dependent kinases and retinoblastoma phosphorylation.</clue>
<comment>CAUTION: SEE, indistinguishable</comment></event>
<sentence id="S5">In addition, we show that <term id="T25" lex="PNU156804" sem="Organic_compound_other">PNU156804</term> does not block significantly the induction of either <term id="T26" lex="IL-2" sem="Protein_molecule">IL-2</term> or <cons id="T27" lex="(AND IL-2R_alpha-chain IL-2R_gamma-chain)" sem="(AND Protein_molecule Protein_molecule)"><frag id="F4">IL-2R</frag> <frag id="F5">alpha-</frag> and <frag id="F6">gamma-</frag><frag id="F7">chains</frag></cons> but inhibits <term id="T28" lex="IL-2-dependent_T_cell_proliferation" sem="Other"><term id="T29" lex="IL-2" sem="Protein_molecule">IL-2</term>-dependent <term id="A5" sem="Cell_natural">T cell</term> proliferation</term>.</sentence>
<event KT="Analysis" Manner="High" Polarity="Negative" assertion="non-exist" id="E16">
<type class="Negative_regulation"/>
<theme idref="E19"/>
<cause idref="T25"/>
<clue>In addition, we <clueKT>show</clueKT> that PNU156804 does <cluePolarity>not</cluePolarity> <clueType>block</clueType> <clueManner>significantly</clueManner> the induction of either IL-2 or IL-2R alpha- and gamma-chains but inhibits IL-2-dependent T cell proliferation.</clue>
</event>
<event KT="Analysis" Manner="High" Polarity="Negative" assertion="non-exist" id="E17">
<type class="Negative_regulation"/>
<theme idref="E20"/>
<cause idref="T25"/>
<clue>In addition, we <clueKT>show</clueKT> that PNU156804 does <cluePolarity>not</cluePolarity> <clueType>block</clueType> <clueManner>significantly</clueManner> the induction of either IL-2 or IL-2R alpha- and gamma-chains but inhibits IL-2-dependent T cell proliferation.</clue>
</event>
<event KT="Analysis" Manner="High" Polarity="Negative" assertion="non-exist" id="E18">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="T25"/>
<clue>In addition, we <clueKT>show</clueKT> that PNU156804 does <cluePolarity>not</cluePolarity> <clueType>block</clueType> <clueManner>significantly</clueManner> the induction of either IL-2 or IL-2R alpha- and gamma-chains but inhibits IL-2-dependent T cell proliferation.</clue>
</event>
<event KT="Other" id="E19">
<type class="Positive_regulation"/>
<theme idref="T26"/>
<clue>In addition, we show that PNU156804 does not block significantly the <clueType>induction</clueType> <linkTheme>of</linkTheme> either IL-2 or IL-2R alpha- and gamma-chains but inhibits IL-2-dependent T cell proliferation.</clue>
</event>
<event KT="Other" id="E20">
<type class="Positive_regulation"/>
<theme idref="F4" idref1="F5" idref2="F7"/>
<clue>In addition, we show that PNU156804 does not block significantly the <clueType>induction</clueType> <linkTheme>of</linkTheme> either IL-2 or IL-2R alpha- and gamma-chains but inhibits IL-2-dependent T cell proliferation.</clue>
</event>
<event KT="Other" id="E21">
<type class="Positive_regulation"/>
<theme idref="F4" idref1="F6" idref2="F7"/>
<clue>In addition, we show that PNU156804 does not block significantly the <clueType>induction</clueType> <linkTheme>of</linkTheme> either IL-2 or IL-2R alpha- and gamma-chains but inhibits IL-2-dependent T cell proliferation.</clue>
</event>
<event KT="Analysis" id="E22">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="T25"/>
<clue>In addition, we <clueKT>show</clueKT> that PNU156804 does not block significantly the induction of either IL-2 or IL-2R alpha- and gamma-chains but <clueType>inhibits</clueType> IL-2-dependent T cell proliferation.</clue>
</event>
<event KT="Other" id="E23">
<type class="Regulation"/>
<theme idref="E24"/>
<cause idref="T29"/>
<clue>In addition, we show that PNU156804 does not block significantly the induction of either IL-2 or IL-2R alpha- and gamma-chains but inhibits IL-2-<clueType>dependent</clueType> T cell proliferation.</clue>
</event>
<event KT="Other" id="E24">
<type class="Cellular_physiological_process"/>
<theme idref="A5"/>
<clue>In addition, we show that PNU156804 does not block significantly the induction of either IL-2 or IL-2R alpha- and gamma-chains but inhibits IL-2-dependent T cell <clueType>proliferation</clueType>.</clue>
</event>
<sentence id="S6">We have investigated several <term id="T30" lex="molecular_pathway" sem="Other">molecular pathways</term> that are known to be activated by <term id="T31" lex="IL-2" sem="Protein_molecule">IL-2</term> in <term id="T32" lex="T_cell" sem="Cell_natural">T cells</term>.</sentence>
<event KT="Fact" id="E25">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<cause idref="T31"/>
<clue>We have investigated several molecular pathways that are <clueKT>known</clueKT> to be <clueType>activated</clueType> <linkCause>by</linkCause> IL-2 <clueLoc>in T cells</clueLoc>.</clue>
</event>
<sentence id="S7">We show that <term id="T33" lex="PNU156804" sem="Organic_compound_other">PNU156804</term> does not inhibit <cons id="T34" lex="(AND c-myc_mRNA_induction bcl-2_mRNA_induction)" sem="(AND Other Other)"><frag id="F8"><term id="A10" sem="RNA_molecule">c-myc</term></frag> and <frag id="F9"><term id="A11" sem="RNA_molecule">bcl-2</term></frag> <frag id="F10"><term id="A12" sem="RNA_molecule">mRNA</term> induction</frag></cons>.</sentence>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E26">
<type class="Negative_regulation"/>
<theme idref="E28"/>
<cause idref="T33"/>
<clue>We <clueKT>show</clueKT> that PNU156804 does <cluePolarity>not</cluePolarity> <clueType>inhibit</clueType> c-myc and bcl-2 mRNA induction.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E27">
<type class="Negative_regulation"/>
<theme idref="E29"/>
<cause idref="T33"/>
<clue>We <clueKT>show</clueKT> that PNU156804 does <cluePolarity>not</cluePolarity> <clueType>inhibit</clueType> c-myc and bcl-2 mRNA induction.</clue>
</event>
<event KT="Other" id="E28">
<type class="Positive_regulation"/>
<theme idref="A10" idref1="A12"/>
<clue>We show that PNU156804 does not inhibit c-myc and bcl-2 mRNA <clueType>induction</clueType>.</clue>
</event>
<event KT="Other" id="E29">
<type class="Positive_regulation"/>
<theme idref="A11" idref1="A12"/>
<clue>We show that PNU156804 does not inhibit c-myc and bcl-2 mRNA <clueType>induction</clueType>.</clue>
</event>
<sentence id="S8">On the other hand, <term id="T35" lex="PNU156804" sem="Organic_compound_other">PNU156804</term> efficiently inhibits the activation of the <term id="T36" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> and <term id="T37" lex="AP-1" sem="Protein_molecule">AP-1</term> transcription factors.</sentence>
<event id="E30">
<type class="Negative_regulation"/>
<theme idref="E32"/>
<cause idref="T35"/>
<clue>On the other hand, PNU156804 efficiently <clueType>inhibits</clueType> the activation of the NF-kappa B and AP-1 transcription factors.</clue>
</event>
<event id="E31">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<cause idref="T35"/>
<clue>On the other hand, PNU156804 efficiently <clueType>inhibits</clueType> the activation of the NF-kappa B and AP-1 transcription factors.</clue>
</event>
<event KT="Other" id="E32">
<type class="Positive_regulation"/>
<theme idref="T36"/>
<clue>On the other hand, PNU156804 efficiently inhibits the <clueType>activation</clueType> <linkTheme>of</linkTheme> the NF-kappa B and AP-1 transcription factors.</clue>
</event>
<event KT="Other" id="E33">
<type class="Positive_regulation"/>
<theme idref="T37"/>
<clue>On the other hand, PNU156804 efficiently inhibits the <clueType>activation</clueType> <linkTheme>of</linkTheme> the NF-kappa B and AP-1 transcription factors.</clue>
</event>
<sentence id="S9"><term id="T38" lex="PNU156804" sem="Organic_compound_other">PNU156804</term> inhibition of <term id="T39" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activation is due to the inhibition of the degradation of <term id="T40" lex="I_kappa_B-alpha" sem="Protein_molecule">I kappa B-alpha</term> and <term id="T41" lex="I_kappa_B-beta" sem="Protein_molecule">I kappa B-beta</term>.</sentence>
<event id="E34">
<type class="Negative_regulation"/>
<theme idref="E35"/>
<cause idref="T38"/>
<clue>PNU156804 <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappa B activation is due to the inhibition of the degradation of I kappa B-alpha and I kappa B-beta.</clue>
</event>
<event KT="Other" id="E35">
<type class="Positive_regulation"/>
<theme idref="T39"/>
<clue>PNU156804 inhibition of NF-kappa B <clueType>activation</clueType> is due to the inhibition of the degradation of I kappa B-alpha and I kappa B-beta.</clue>
</event>
<event id="E36">
<type class="Positive_regulation"/>
<theme idref="E34"/>
<cause idref="E38"/>
<clue>PNU156804 inhibition of NF-kappa B activation is <clueType>due</clueType> <linkCause>to</linkCause> the inhibition of the degradation of I kappa B-alpha and I kappa B-beta.</clue>
</event>
<event id="E37">
<type class="Positive_regulation"/>
<theme idref="E34"/>
<cause idref="E39"/>
<clue>PNU156804 inhibition of NF-kappa B activation is <clueType>due</clueType> <linkCause>to</linkCause> the inhibition of the degradation of I kappa B-alpha and I kappa B-beta.</clue>
</event>
<event id="E38">
<type class="Negative_regulation"/>
<theme idref="E40"/>
<cause idref="T38"/>
<clue>PNU156804 inhibition of NF-kappa B activation is due to the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> the degradation of I kappa B-alpha and I kappa B-beta.</clue>
</event>
<event id="E39">
<type class="Negative_regulation"/>
<theme idref="E41"/>
<cause idref="T38"/>
<clue>PNU156804 inhibition of NF-kappa B activation is due to the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> the degradation of I kappa B-alpha and I kappa B-beta.</clue>
</event>
<event KT="Other" id="E40">
<type class="Protein_catabolism"/>
<theme idref="T40"/>
<clue>PNU156804 inhibition of NF-kappa B activation is due to the inhibition of the <clueType>degradation</clueType> <linkTheme>of</linkTheme> I kappa B-alpha and I kappa B-beta.</clue>
</event>
<event KT="Other" id="E41">
<type class="Protein_catabolism"/>
<theme idref="T41"/>
<clue>PNU156804 inhibition of NF-kappa B activation is due to the inhibition of the <clueType>degradation</clueType> <linkTheme>of</linkTheme> I kappa B-alpha and I kappa B-beta.</clue>
</event>
<sentence id="S10"><term id="T42" lex="PNU156804" sem="Organic_compound_other">PNU156804</term> action is restricted to some <term id="T43" lex="signaling_pathway" sem="Other">signaling pathways</term>; it does not affect <term id="T44" lex="NF-kappa_B_activation" sem="Other"><term id="T45" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> activation</term> by <term id="T46" lex="PMA" sem="Organic_compound_other">PMA</term> in <term id="T47" lex="T_cell" sem="Cell_natural">T cells</term> but blocks that induced by <term id="T48" lex="CD40_cross-linking" sem="Other"><term id="T49" lex="CD40" sem="Protein_molecule">CD40</term> cross-linking</term> in <term id="T50" lex="B_lymphocyte" sem="Cell_natural">B lymphocytes</term>.</sentence>
<event id="E42">
<type class="Regulation"/>
<theme idref="T43"/>
<cause idref="T42"/>
<clue>PNU156804 <clueType>action</clueType> is restricted <linkTheme>to</linkTheme> some signaling pathways; it does not affect NF-kappa B activation by PMA in T cells but blocks that induced by CD40 cross-linking in B lymphocytes.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E43">
<type class="Regulation"/>
<theme idref="E44"/>
<cause idref="T42"/>
<clue>PNU156804 action is restricted to some signaling pathways; it does <cluePolarity>not</cluePolarity> <clueType>affect</clueType> NF-kappa B activation by PMA in T cells but blocks that induced by CD40 cross-linking in B lymphocytes.</clue>
</event>
<event id="E44">
<type class="Positive_regulation"/>
<theme idref="T45"/>
<cause idref="T46"/>
<clue>PNU156804 action is restricted to some signaling pathways; it does not affect NF-kappa B <clueType>activation</clueType> <linkCause>by</linkCause> PMA <clueLoc>in T cells</clueLoc> but blocks that induced by CD40 cross-linking in B lymphocytes.</clue>
</event>
<event id="E45">
<type class="Negative_regulation"/>
<theme idref="E46"/>
<cause idref="T42"/>
<clue>PNU156804 action is restricted to some signaling pathways; it does not affect NF-kappa B activation by PMA in T cells but <clueType>blocks</clueType> that induced by CD40 cross-linking in B lymphocytes.</clue>
</event>
<event KT="Other" id="E46">
<type class="Positive_regulation"/>
<theme idref="T45"/>
<cause idref="E47"/>
<clue>PNU156804 action is restricted to some signaling pathways; it does not affect NF-kappa B activation by PMA in T cells but blocks <corefTheme>that</corefTheme> <clueType>induced</clueType> <linkCause>by</linkCause> CD40 cross-linking <clueLoc>in B lymphocytes</clueLoc>.</clue>
</event>
<event KT="Other" id="E47">
<type class="Binding"/>
<theme idref="T49"/>
<clue>PNU156804 action is restricted to some signaling pathways; it does not affect NF-kappa B activation by PMA in T cells but blocks that induced by CD40 <clueType>cross-linking</clueType> in B lymphocytes.</clue>
</event>
<sentence id="S11">We conclude that the <term id="T51" lex="prodigiosin_family" sem="Organic_compound_other">prodigiosin family</term> of <term id="T52" lex="immunosuppressant" sem="Organic_compound_other">immunosuppressants</term> is a new family of molecules that show a novel target specificity clearly distinct from that of other <term id="T53" lex="immunosuppressive_drug" sem="Organic_compound_other">immunosuppressive drugs</term> such as <term id="T54" lex="cyclosporin_A" sem="Organic_compound_other">cyclosporin A</term>, <term id="T55" lex="FK506" sem="Organic_compound_other">FK506</term>, and <term id="T56" lex="rapamycin" sem="Organic_compound_other">rapamycin</term>.</sentence>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
